E7 TCR cell induction immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for E7 TCR cell induction immunotherapy, covering 2022-02-01 to 2022-02-01. Get the full timeline:
Most recent: Clinical Trial Update: E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer [Phase 2]